期刊文献+

子宫内膜癌治疗应关注的几个问题 被引量:8

Some Questions of Endometrial Carcinoma Treatment
下载PDF
导出
摘要 子宫内膜癌是常见的妇科恶性肿瘤,关于其诊断和治疗国内外均有诊治指南,但是在治疗方面还存在一些问题,应引起广大妇科肿瘤工作者关注。如,早期子宫内膜癌患者子宫切除范围和淋巴结是否有必要切除,子宫内膜癌内分泌治疗的必要性,年轻的早期子宫内膜癌患者能否保留生育功能等。针对上述问题进行简要论述。 Endometrial carcinoma is one of the common gynecological cancers. The guidelines of diagnosis and treatment of endometrial carcinoma have been used for many years in China and worldwide. However, some questions about endometrial carcinoma treatment such as hysterectomy and lymphodenectomy for early stage patient with endometrial carcinoma, endocrinal therapy, preserve fertility for the early stage endometrial carcinoma in young people, are still uncertain. This article shall review related data and discuss above questions briefly.
作者 王建六
出处 《国际妇产科学杂志》 CAS 2010年第4期227-229,共3页 Journal of International Obstetrics and Gynecology
关键词 子宫内膜肿瘤 子宫切除术 淋巴结切除术 淋巴转移 治疗 Endometrial neoplasms Hysterectomy Lymph node excision Lymphatic metastasis Therapy
  • 相关文献

参考文献8

二级参考文献40

  • 1王美清,张庆慧,郭玲玲,蔡毅然,王妍.40岁以下妇女子宫内膜癌刮宫活检的病理诊断问题[J].中华病理学杂志,2005,34(5):262-265. 被引量:14
  • 2Gruber T, Dare AO, Balos LL, et al. Multiple meningiomas arising during long-term therapy with the progesterone agonist megestrol acetate. Case report. J Neurosurg,2004, 100:328-331.
  • 3Makarov OV, Sergeev PV, Sviridov NK, et al. Effect of gestagen therapy on clinical and biochemical parameters in patients with atypical endometrial hyperplasia. Vopr Onkol,2000,46:570-573.
  • 4Nola M, Jukic S, Ilic-Forko J, et al. Effects of tamoxifen on steroid hormone receptors and hormone concertration and the results of DNA analysis bu flow cytometry in endometrial carcinoma. Gynecol Oncol,1999,72:331-336.
  • 5Jobo T, Kawaguchi M, Imai M, et al. Treatment for complex atypical hyperplasia of the endometrium. Eur J Gynaecol Oncol,2001,22:365-368.
  • 6Thigpen JT, Brady MF, Alvarez RD, et al. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol,1999,17:1736-1744.
  • 7Imai M, Jobo T, Sato R, et al. Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations. Eur J Gynaecol Oncol,2001,22:217-220.
  • 8Mikuta JJ. International Federation of Gynecology and Obstertrics staging of endometrial cancer 1988. Cancer, 1993, 71:1460-1463.
  • 9von Minckwitz G, Loibl S, Brunnert K, et al. Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer--a multicentre, open, controlled, prospectively randomised trial. Eur J Cancer,2002,38:2265-2271.
  • 10Vishnevsky AS, Bokhman YaV, Loutfi G. Favourable influence of adjuvant hormone therapy by oxyprogesterone caproate (OPC) and by its combination with tamoxifen on 5-year survival rate of surgical and combined treatment of primary endometrial carcinoma patients. Eur J Gynaecol Oncol,1993,14:150-153.

共引文献48

同被引文献50

引证文献8

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部